新入荷 再入荷

Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer

flash sale icon タイムセール
終了まで
00
00
00
999円以上お買上げで送料無料(
999円以上お買上げで代引き手数料無料
通販と店舗では販売価格や税表示が異なる場合がございます。また店頭ではすでに品切れの場合もございます。予めご了承ください。
新品 10800円 (税込)
数量

Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer

Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as  the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10):  Potential Lead Molecules for Treatment of Colon CancerDiscovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer,Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as  the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10):  Potential Lead Molecules for Treatment of Colon CancerDiscovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer,Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as  the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10):  Potential Lead Molecules for Treatment of Colon CancerDiscovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer,Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as  the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10):  Potential Lead Molecules for Treatment of Colon CancerDiscovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer,Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as  the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10):  Potential Lead Molecules for Treatment of Colon CancerDiscovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer

 

商品情報の訂正

このページに記載された商品情報に記載漏れや誤りなどお気づきの点がある場合は、下記訂正依頼フォームよりお願い致します。

訂正依頼フォーム

商品レビュー

レビューの投稿にはサインインが必要です